Webinar

Novel Agents for the Treatment of AL Amyloidosis: Dr. Tibor Kovacsovics – ASG Webinar 3/13

Amyloidosis Support Groups’ webinar for light chain (AL) amyloidosis was hosted on January 15, 2022. Led by ASG President Muriel Finkel, this webinar discusses the current treatments for light chain amyloidosis and features amyloidosis expert: Dr. Tibor Kovacsovics, Hematologist, Professor (Clinical), Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Novel Agents for the Treatment of AL Amyloidosis: Dr. Tibor Kovacsovics – ASG Webinar 3/13 Read More »

Novel Agent Venetoclax and Translocation 11;14 Subtype – ASG Webinar 8/13

Amyloidosis Support Groups’ webinar for light chain (AL) amyloidosis patients and caregivers in the Northeast region on September 18, 2021. Led by ASG President Muriel Finkel, this webinar discusses the current treatments for light chain amyloidosis and features amyloidosis expert: Heather J. Landau, MD, Hematologic Oncologist at Memorial Sloan Kettering Cancer Center, New York, NY.

Novel Agent Venetoclax and Translocation 11;14 Subtype – ASG Webinar 8/13 Read More »

Nico Cheek-O’Donnell: Coping With Amyloidosis – ASG Webinar 4/6

The Amyloidosis Support Group webinar recorded on April 17, 2021, focused on the mental health aspects of coping with this life-altering disease. Muriel Finkel, ASG President, led the webinar and Q&A session. The webinar is presented by: Nico Cheek O’Donnell, Clinical Social Worker at the Utah Amyloidosis Program, Huntsman Cancer Institute in Salt Lake City.

Nico Cheek-O’Donnell: Coping With Amyloidosis – ASG Webinar 4/6 Read More »

Scroll to Top